Abstract

This study investigated the in vitro toxic effects of Bitis arietans venom and the ability of antivenom produced by the South African Institute of Medical Research (SAIMR) to neutralize these effects. The venom (50 µg/mL) reduced nerve-mediated twitches of the chick biventer muscle to 19% ± 2% of initial magnitude (n = 4) within 2 h. This inhibitory effect of the venom was significantly attenuated by prior incubation of tissues with SAIMR antivenom (0.864 µg/µL; 67% ± 4%; P < 0.05; n = 3–5, unpaired t-test). Addition of antivenom at t50 failed to prevent further inhibition or reverse the inhibition of twitches and responses to agonists. The myotoxic action of the venom (50 µg/mL) was evidenced by a decrease in direct twitches (30% ± 6% of the initial twitch magnitude) and increase in baseline tension (by 0.7 ± 0.3 g within 3 h) of the chick biventer. Antivenom failed to block these effects. Antivenom however prevented the venom induced cytotoxic effects on L6 skeletal muscle cells. Venom induced a marginal but significant reduction in plasma clotting times at concentrations above 7.8 µg/100 µL of plasma, indicating poor procoagulant effects. In addition, the results of western immunoblotting indicate strong immunoreactivity with venom proteins, thus warranting further detailed studies on the neutralization of the effects of individual venom toxins by antivenom.

Highlights

  • IntroductionB. arietans is a species of viper which occupies densely populated habitats throughout the Middle

  • B. arietans is a species of viper which occupies densely populated habitats throughout the MiddleEast and savannah areas of sub-Saharan Africa [1]

  • South African Institute of Medical Research (SAIMR) antivenom is the treatment of choice following envenoming by B. arietans [4]

Read more

Summary

Introduction

B. arietans is a species of viper which occupies densely populated habitats throughout the Middle. Bites by this species are widely believed to contribute to a substantial proportion of the estimated 43,000 deaths from snake bite reported in Africa annually [2]. Polyvalent antivenom produced by South African Institute of Medical Research (SAIMR) is the treatment of choice following B. arietans envenoming [4] This antivenom contains antibodies raised against a range of snake species (B. arietans, B. gabonica, Haemachatus haemachatus, Naja melanoleuca, N. nivea, N. annulifera, Dendroaspis polylepis, D. jameson, D. angusticeps, N. mossambica) found throughout Africa. The neutralisation of venom lethality by antivenoms raised in camels and horses has been examined [8] Such studies fall short of determining the extent to which specific toxic effects are neutralized by the antivenom.

Neurotoxicity
Myotoxicity
Effect of Venom on Cell Viability
Coagulation Studies
Drugs and Chemicals
Venoms and Antivenoms
Neurotoxicity Studies
Myotoxicity Studies
Effect of Venom
Antivenom Effects
Iso-Electric Focusing
SDS-PAGE
Western Immunoblotting
Statistical Analysis
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.